Fluorescence Immunoassay (FIA)
Chemiluminescence Immunoassay (CLIA)
Rapid Test (Colloidal gold)
Quality Control
Chest Pain Center
Stroke Center
Trauma Center
Critical Maternal Care Center
Critical Children and Neonatal Care Center
Center for Reproductive Medicine
Hierarchical diagnosis and treatment
Hospital-wide solution
Oct 29,2024
2024.7~2024.9 Solid Waste Pollution Prevention and Control Information Disclosure
2024.4~2024.6 Solid Waste Pollution Prevention and Control Information Disclosure
Feb 08,2024
Medlab Dubai 2024
Nov 14,2023
The first day of MEDICA 2023 is coming
Aug 08,2019
On December 27, 2019, Guangdong Weishi Biotechnology Co., Ltd. was officially established.
Aug 14,2020
In 2020, the new crown virus test kit entered the white list of epidemic prevention medical materials of the Ministry of Commerce and ISO13485 the quality management system certification.
Aug 14,2021
2021 Debuts CACLP, Releases Handheld Colloidal Gold/Fluorescence Immunoanalyzer
Aug 14,2022
2022 "only" innovation, win the future! Only real new products unveiled 2022 Germany MEDICA medical exhibition
Aug 14,2023
In 2023, the multi-channel immunofluorescence analyzer was officially launched and received wide acclaim in the industry.
May 13,2020
WESAIL Participated in Dongguan New Coronavirus Pneumonia Epidemic Prevention Research Project
As a partner of the project undertaking unit, WESAIL participated in the research and promotion of new coronavirus pneumonia epidemic prevention and control technology in Dongguan City, and was responsible for the research and development of new coronavirus immune POCT reagents. This project was initiated by the Dongguan Science and Technology Bureau, aiming to improve the ability of Dongguan City to prevent and control the epidemic, POCT reagent can quickly detect the new crown virus infection, help doctors quickly confirm the diagnosis, help the epidemic prevention and control.